BRAF V600E is associated with adverse features, including tall cell histological subtypes, macroscopic extrathyroidal extension (ETE), lymph node metastasis, advanced tumor stages, and higher recurrence rates [9,10,14,15,16,17,18]. This evidence concerns the gene BRAF and metastatic malignant neoplasm in the lymph nodes.